45m
KP Tissue Inc (KPTSF) Q1 2026 Earnings Call Highlights: Strong EBITDA Growth Amid Revenue Challenges
KP Tissue Inc (KPTSF) reports a robust 14.6% increase in adjusted EBITDA, despite facing slight revenue decline and escalating input costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results